Sangamo Therapeutics, Inc. (SGMO)
NASDAQ: SGMO · Real-Time Price · USD
0.496
-0.034 (-6.45%)
At close: Dec 5, 2025, 4:00 PM EST
0.497
+0.002 (0.30%)
After-hours: Dec 5, 2025, 7:59 PM EST
Sangamo Therapeutics Employees
Sangamo Therapeutics had 183 employees as of December 31, 2024. The number of employees decreased by 222 or -54.81% compared to the previous year.
Employees
183
Change (1Y)
-222
Growth (1Y)
-54.81%
Revenue / Employee
$179,645
Profits / Employee
-$595,131
Market Cap
166.87M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SGMO News
- 4 days ago - Sangamo Therapeutics Receives U.S. FDA Fast Track Designation for ST-503 for the Treatment of Small Fiber Neuropathy - GlobeNewsWire
- 15 days ago - Sangamo Therapeutics Announces FDA Acceptance of BLA Rolling Submission Request for ST-920 in Fabry Disease - GlobeNewsWire
- 4 weeks ago - Sangamo Therapeutics, Inc. (SGMO) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - Sangamo Therapeutics Announces Third Quarter 2025 Earnings Call - GlobeNewsWire
- 3 months ago - Sangamo Therapeutics Presents Detailed Data from Registrational STAAR Study in Fabry Disease at International Congress of Inborn Errors of Metabolism 2025 - GlobeNewsWire
- 4 months ago - Sangamo Therapeutics, Inc. (SGMO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2025 Financial Results - GlobeNewsWire